Aarkstore.com || Refractory Angina – Pipeline Review, H1 2012 || Market Research latest report

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Refractory Angina – Pipeline Review, H1 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s, Refractory Angina - Pipeline Review, H1 2012, provides an
overview of the Refractory Angina therapeutic pipeline. This report provides
information on the therapeutic development for Refractory Angina, complete with
latest updates, and special features on late-stage and discontinued projects. It also
reviews key players involved in the therapeutic development for Refractory Angina.
Refractory Angina - Pipeline Review, H1 2012 is built using data and information
sourced from Global Markets Direct’s proprietary databases, Company/University
websites, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put together by
Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Refractory Angina.
- A review of the Refractory Angina products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development ranging from

2. discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined
therapeutics.
Table of contents:
List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Refractory Angina Overview 5
Therapeutics Development 6
An Overview of Pipeline Products for Refractory Angina 6
Refractory Angina Therapeutics under Development by Companies 8
Mid Clinical Stage Products 9
Comparative Analysis 9
Refractory Angina Therapeutics – Products under Development by Companies 10
Companies Involved in Refractory Angina Therapeutics Development 11
Ark Therapeutics Group plc 11
Refractory Angina – Therapeutics Assessment 12
Assessment by Monotherapy Products 12
Assessment by Route of Administration 13
Assessment by Molecule Type 15
Drug Profiles 17
EG011 - Drug Profile 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Refractory Angina Therapeutics - Dormant Products 18
Refractory Angina – Product Development Milestones 19
Featured News & Press Releases 19
Jan 28, 2010: First Refractory Angina Patient Treated With VEGF-D Shortform
(EG011) In Phase I/IIa Trial 19
Appendix 21
Methodology 21
Coverage 21

3. Secondary Research 21
Primary Research 21
Expert Panel Validation 21
Contact Us 22
Disclaimer 22
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H1 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H1
2012&PubId=&pagenum=1
Refractory Angina – Pipeline Review, H1 2012
Post-Myocardial Infarction – Pipeline Review, H1 2012
Proteinuria – Pipeline Review, H1 2012
Ocular Pain – Pipeline Review, H1 2012
Pediculosis (Head Lice Infestation) – Pipeline Review, H1 2012
Allergic Rhino-Conjunctivitis – Pipeline Review, H1 2012
Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H1 2012

4. Thyroid Gland Disorders – Pipeline Review, H1 2012
Tinea Corporis – Pipeline Review, H1 2012
Pulmonary Fibrosis – Pipeline Review, H1 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com